Why the study?
Do multimorbidity and polypharmacy impact clinical outcomes in Chinese emergency department patients with atrial fibrillation?
Do multimorbidity and polypharmacy impact clinical outcomes in Chinese emergency department patients with atrial fibrillation?
In Chinese emergency department patients with atrial fibrillation, multimorbidity is associated with worse clinical outcomes, and CAD along with antiplatelet therapy predict the non-use of vitamin K antagonists.
Multimorbidity signals higher risk in Chinese ED AF; hypothesis-generating for optimizing VKA use amid CAD or antiplatelet therapy.
Multimorbidity was associated with worse outcomes in Chinese ED AF patients. Polypharmacy showed no significant statistics among these outcomes. CAD and antiplatelet therapy were independent risk factors of VKA non-use in Chinese ED AF patients with multimorbidity or polypharmacy.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: